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6 MEDICAL SCREENING AND SURVEILLANCE 
6.1 OBJECTIVES OF MEDICAL SCREENING AND SURVEILLANCE 
The REL of 1 mg/m3 for respirable coal mine dust does not assure a zero risk for the development 
of occupational respiratory diseases among all miners exposed during a full working lifetime. 
Consequently, a medical screening and surveillance program that includes initial and periodic chest 
X-rays and spirometric examinations is important for the early detection of disease and the 
prevention of "material impairment of health or functional capacity" [30 USC 8 11(a)(6)(A)]. The 
medical screening and surveillance program is also useful for disease surveillance, which incIudes 
the tracking trends, the setting of prevention and intervention priorities, and the assessment of 
prevention and intervention efforts. NIOSH encourages both underground and surface coal miners 
to participate in the medical screening and surveillance program. 
6.1.1 Definitions 
Medical screening is "the application of an examination, historical question, or laboratory test to 
apparently healthy persons with the goal of detecting absorption of intoxicants or early pathology 
before the worker would normally seek clinical care for symptomatic disease" [Halperin et al. 
19861. In contrast, medical surveillance involves the evaluation of a population's health status 
through the periodic collection, analysis, and reporting of data for the purpose of disease prevention 
[Halperin and Baker 19921. Medical surveillance data are useful for evaluating the effectiveness 
of disease prevention and intervention programs. Primary prevention of work-related disease 
depends on the effective control of worker exposures below occupational exposure limits. 
Secondary prevention measures include medical screening for the early detection of diseases and 
medical intervention, which is aimed at reversing or impeding progression of disease. 
6.1.2 Criteria for Medical Screening and Surveillance Tests 
Acceptable performance of a medical screening test depends on the prevalence of disease in the 
population as well as the risk of toxicity and the consequences of false positive test results [Matte 
et al. 19901. Additional criteria for effective medical screening tests and programs include the 
following [Weeks et al. 1991; Levy and Halperin 19881: 
The screening test must have acceptable sensitivity, specificity, and predictive value. 
The screening test must be valid and reliable. 
The screening test must identify disease early and lead to treatment that impedes disease 
progression. 
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Adequate followup, further diagnostic tests, and effective management of the disease must 
be available, accessible, and acceptable. 
Benefits of the screening program must outweigh the costs. 
If a medical screening test indicates the presence of a disease or the increased probability of the 
presence of disease, further evaluation and diagnostic testing are needed. 
NIOSH believes that the tests recommended in the,medical screening and surveillance program 
for coal miners (i.e., chest X-rays and spirometry) reasonably fulfill the criteria for effective 
screening tests. These recommended tests are performed using standardized methods for admin- 
istering them and interpreting results. They represent the best available methods for detecting 
occupation-related respiratory diseases among coal miners. In addition to the medical screening 
function, the recommended tests are also important for medical surveillance. The characteristics 
of medical tests used in disease surveillance of a population may differ from those required for the 
clinical evaluations of individuals [Weeks et al. 1991; Silverstein 19901. 
6.2 CURRENT MEDICAL SURVEILLANCE PROGRAM AND RECOMMENDED 
REVISIONS 
6.2.1. Current Chest X-Ray Program 
The Coal Workers' X-Ray Surveillance Program was established under the Federal Coal Mine 
Health and Safety Act of 1969 (P.L. 91- 173), which was amended by the Federal Mine Safety and 
Health Act of 1977 130 USC 8431. The specifications for giving, interpreting, classifying, and 
submitting chest X-rays for underground coal miners are provided in 42 CFR 37. Currently, 
mandatory X-rays include the following: 
An initial chest X-ray within 6 months of beginning employment 
Another chest X-ray 3 years after the initial examination 
A third chest X-ray 2 years following the second one if a miner is still engaged in underground 
coal mining and if the second chest X-ray shows evidence of category 1 or higher 
pneumoconiosis according to the ILO classification [ILO 19801 
In addition to these mandatory chest X-rays, mine operators are required to offer an opportunity 
for periodic, voluntary chest X-rays approximately every 5 years. These chest X-rays must be 
interpreted by approved, qualified readers [42 CFR Part 371. Radiographic findings of simple 
CWP or PMF are reported to MSHA by NIOSH and to the miners by MSHA. All chest X-rays 
given under the Coal Workers' X-Ray Surveillance Program are submitted to and become the 
property of NIOSH. Operators of underground coal mines are required to provide chest X-rays at 
a convenient time and place for all miners who work in underground coal mines or in surface areas 
of underground coal mines [42 CFR Part 371. 
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6.2.2 Spirometry Recommendations 
The Federal Coal Mine Safety and Health Act of 1977 specifies that the chest X-rays are to be 
supplemented by "such other tests as the Secretary of Health and Human Services deems 
necessary" [30 USC 843(a)]. The definition of pneumoconiosis was modified in the Black Lung 
Benefits Reform Act of 1977 as a chronic dust disease of the lung and its sequelae, including 
respiratory and pulmonary impairments arising out of "coal mine employment" [30 USC 
902(b)]. NIOSH therefore recommends that spirometric examinations be included in the medical 
screening and surveillance program for coal miners based on 
- the definition of pneumoconiosis in the Black Lung Benefits Reform Act of 1977 (which 
includes respiratory and pulmonary impairments that might not be detected on a chest 
X-ray but would be detected with spirometry), and 
- the evidence (see Chapters 4 and 7) that coal miners can develop COPD from their 
exposures to respirable coal mine dust-even without radiographic evidence of simple 
CWP and apart from the effects of cigarette smoking. 
The recommended schedule for spirometric examinations is provided in Section 6.3. 
6.2.3 Recommendations for Surface Coal Miners 
NIOSH also recommends inclusion of surface coal miners in the medical screening and surveil- 
lance program based on the evidence (see Chapters 4 and 7) that these miners can develop simple 
CWP, PMF, silicosis, and decrements in lung function as a result of their exposures to respirable 
coal mine dust and respirable crystalline silica. 
6.2.4 Current and Recommended Option to Work in a Low-Dust Environment 
Currently, any miner who shows evidence of the development of pneumoconiosis based on the 
chest X-ray or other medical examinations has the option to work in a low-dust environment in 
the mine where the concentration of respirable coal mine dust is not more than 1.0 mg/m3-or 
where the concentration is the lowest attainable below 2.0 mg/m3 if the 1.0 mg/m3 concentration 
is not attainable in the mine where the miner works [30 USC 843(b)]. If it is necessary for the 
miner to transfer to another position in the mine to reduce exposure, the transfer is offered without 
loss of pay. These miners also receive periodic personal exposure monitoring [30 CFR 901. 
The current regulations [30 CFR 901 include only underground coal miners and workers at surface 
work areas of underground coal mines. NIOSH recommends that the regulations governing 
eligibility and procedures for the transfer option be amended to include both surface and under- 
ground coal miners with radiographic evidence of pneumoconiosis or with confirmed finding of 
a chronic airways disease based on spirometry and other medical examinations or tests deemed 
necessary by a licensed physician. NIOSH believes that affording miners with evidence of 
occupation-related respiratory disease the opportunity to work in a low-dust environment is 
consistent with the intent of the Americans with Disabilities Act of 1990 [42 USC 10227-136431. 
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6.3 RECOMMENDED MEDICAL SCREENING AND SURVEILLANCE PROGRAM FOR 
UNDERGROUND AND SURFACE COAL MINERS 
This document refers to the recommended revisions to the Coal Workers' X-Ray Surveillance 
Program as the "Coal Workers' Medical Screening and Surveillance Program" to better reflect the 
functions of the program. The recommended preplacement and periodic medical examinations 
include the following: 
An initial (preplacement) spirometric examination and chest X-ray as soon as possible after 
beginning employment (within 3 months for a spirometric examination and within 3 to 6 
months for a chest X-ray) 
A spirometric examination each year for the first 3 years after beginning employment and 
every 2 to 3 years thereafter if the miner is still engaged in coal mining 
A chest X-ray every 4 to 5 years for the first 15 years of employment and every 3 years 
thereafter if the miner is still engaged in coal mining 
A chest X-ray and spirometric examination when employment ends if more than 6 months 
have passed since the last examination 
A standardized respiratory symptom questionnaire-such as the American Thoracic Soci- 
ety (ATS) respiratory questionnaire [Ferris 1978 (or the most current equivalent)]-to be 
administered at the preplacement examination and updated at each periodic examination 
A standardized occupational history questionnaire (including a listing of all jobs held up 
to and including present employment, a description of all duties and potential exposures, 
and a description of all protective equipment the miner has used or may be required to use) to 
be administered at the preplacement examination and updated at each periodic examination 
6.3.1 Worker Participation 
Miners should be provided with information about the purposes of the medical screening and 
surveillance program, the health-protection benefits of participation, and a description of the 
procedural aspects of the program. This information should include how screening test results are 
used, what actions may be taken based on screening results, who has access to screening test results, 
and how confidentiality is maintained [Matte et al. 19901. The initial examination (which is 
currently mandatory) is important for providing baseline values for individuals. Comparing test 
results for an individual (including baseline values) may indicate a clinically important change that 
would not be apparent from comparing an individual's results with group reference values. The 
reason is that normal variation in test results among healthy group members is generally greater 
than test-to-test variation in individuals [Hankinson and Wagner 1993; Matte et al. 19901. The 
fact that periodic examinations are voluntary may improve the reliability of data based on 
questionnaires and medical tests requiring worker cooperation. Each miner should sign a consent 
form indicating that he or she has been informed about the purposes of the medical screening and 
surveillance program and accepts or declines participation. Miners should not suffer consequences 
because of their choices for or against participation. Recent improvements in the Coal Workers' 
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X-Ray Surveillance Program (including increased education and communication) have resulted in 
an encouraging increase in the voluntary participation of coal miners [Wagner et al. 1993al. 
6.3.2 NIOSH-Approved Facilities 
NIOSH recommends that each mine operator make arrangements with a local MOSH-approved 
facility or organization to conduct the medical examinations. The local examination facility or 
organization should transmit to NIOSH all chest X-rays, pulmonary function test results (including 
spirograms), completed medical questionnaires, and work histories. NIOSH shall evaluate the 
technical quality of the chest X-rays and interpret them. In addition, NIOSH shall do the following: 
Evaluate the results of spirometric examinations, completed medical questionnaires, and 
work histories 
Prepare letters to notify miners of the examination results and to recommend any followup 
examinations 
Permanently store the medical and questionnaire data 
6.3.3 Smoking 
NIOSH recommends that the mine operator prohibit smoking and strictly enforce this policy in all 
underground and surface coal mines and in all other work areas associated with coal mining. The 
mine operator or the physician should counsel tobacco-smoking miners about their increased risk 
of developing lung cancer and COPD; the mine operator or physician should also counsel such 
miners to participate in a smoking cessation program. 
6.4 INTERPRETATION OF MEDICAL SCREENING EXAMINATIONS 
6.4.1 Evidence of Pneumoconiosis on Chest X-Rays 
NIOSH recommends that chest X-rays be classified according to the 1980 ILO Classification of 
Radiographs of Pneumoconioses (or the most current equivalent) [42 CFR 37 (1989)l. Evidence 
of pneumoconiosis is present when the chest X-ray is classified as ILO category 110 or greater or 
when large shadows are recorded as likely to be due to PMF or complicated CWP. NIOSH 
considers two physicians to be in agreement when their classifications meet one of the following 
criteria: 
They each find complicated pneumoconiosis of any category. 
Their findings with regard to simple pneumoconiosis are both in the same major category. 
Their findings are within one minor category (ILO category 12-point scale) of each other. 
In this case, the higher of the two interpretations should be reported. The only exception 
to this criterion is a reading sequence of 011, 110, or 110, 011. Such a sequence is not 
considered agreement, and additional classifications are required until the readers reach a 
consensus involving two or more readings in the same major category. 
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. 6.4.2 Evaluation of Spirometric Examinations 
NIOSH recommends that the results of spirometric examinations be evaluated as follows: 
Use the highest FEVl and FVC values from each miner's examination when comparing 
the FEVl, FVC, and FEV~/FVC%* with the lower limit of normal (LLN)~. 
Compute the miner's decline in FEVl by comparing his or her FEVl values over a period 
of time; a decline of 15% or greater (adjusted for the expected interval decline in FEV1) is 
considered significant and warrants further medical evaluation [Hankinson and Wagner 
1993; ATS 19911. 
A spirometric examination should be repeated within 3 months if it is unacceptable according to 
ATS criteria [ATS 199 11. 
Evidence of impaired lung function is present when there is a confirmed finding (based on two or 
more spirometric examinations) of either of the following: 
The FEVl, FVC, or FEVl/FVC value from an acceptable test is below the LLN (Knudson 
et al. [I9831 and Appendix E, or the most current equivalent). 
A decline in FEVl (adjusted for the expected interval decline in FEV1) is 15% or greater 
[Hankinson and Wagner 1993; ATS 199 11. 
6.4.3 Worker Notification 
Workers should be notified in a timely manner regarding the results of their medical examinations, 
including whether or not any abnormalities were detected. A NIOSH contact person should be 
provided for further information. 
When a miner first shows evidence of impaired lung function based on the results of the spirometric 
examination (Section 6.4.2), he or she should be notified that the spirometric examination should 
be repeated within 3 months. 
Any miner with either radiographic evidence of pneumoconiosis (as described in Section 6.4.1) 
or a confirmed finding of impaired lung function (as described in Section 6.4.2) should be notified 
of his or her option to work in an environment where the exposures are as far as feasible below 
the RELs for respirable coal mine dust and respirable crystalline silica. In addition, the miner 
should be advised to consult a licensed physician or other qualified health care provider regarding 
appropriate medical followup and intervention measures, which may include those listed in 
Section 6.4.4. 
fo he ratio of FEVllFVC is conventionally expressed as a percentage. The miner's highest FEVl and FVC values are 
used to compute this ratio. 
'The LLN is calculated with the equations published by Knudson et al. [I9831 (Appendix E) or the most current 
equivalent. See Section 6.5.4 for a discussion of the LLN. 
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6.4.4 Medical Followup and Intervention 
Medical followup and intervention that should be considered by the physician and the miner 
include the following measures: 
Further medical examination and testing determined by and performed by or under the 
direction of a licensed physician 
Annual spirometric examination 
Participation in a smoking-cessation program, if applicable 
The option to work in an environment with exposures as far as feasible below the RELs 
for respirable coal mine dust and respirable crystalline silica 
6.5 LUNG FUNCTION TESTS FOR MEDICAL SCREENING AND SURVEILLANCE 
Spirometry is the most important test for evaluating a miner's lung function [Attfield and Wagner 
1992bl. The most widely accepted spirometry tests for screening workers are those for FEVl and 
FVC [Hankinson 19861. The detection of lung function values below normal reference values or 
the detection of a significant decline in lung function over time indicates that further examination 
and testing are needed to confirm the test results, to determine the cause(s) of the reduced lung 
function, and to identify appropriate intervention or therapeutic measures. 
6.5.1 Determining Obstructive and Restrictive Ventilatory Defects 
Obstructive and restrictive ventilatory defects are two basic disease patterns detected by spirom- 
etry. An obstructive ventilatory defect indicates airflow limitation caused by airway narrowing 
during expiration [ATS 199 11. A greater reduction in FEVl than in VC (i.e., FEVl/FVC decreased) 
suggests an obstructive ventilatory defect [ATS 19911. Diseases associated with this pattern 
include asthma, chronic bronchitis, and emphysema [Garay 19921. 
Reduced VC and normal or increased FEVl/FVC suggest a restrictive ventilatory defect [ATS 
199 11. Pneumoconiosis and other interstitial lung diseases can cause restrictive ventilatory defects. 
Exposure to respirable coal mine dust may cause obstructive, restrictive, or mixed ventilatory 
defects. 
FEVl is ideal as a screening tool because it detects ventilatory defects reflecting either restrictive 
or obstructive patterns. However, FEVl should not be used without the FEV~/FVC* ratio to 
distinguish between disease patterns because FEVl may be decreased in both the obstructive and 
restrictive patterns, as shown here: 
$FVC may be lower than VC in persons with airways obstruction because of gas trapping; thus, the ratio of FEVl/FVC 
appears to be more normal than the ratio of FEVi/VC. For this reason, the ATS recommends using FEVI/VC to 
determine the ventilatory disease pattern [ATS 19911. However, FVC is used for screening because it is easily 
obtained when measuring FEVI. 
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Obstructive pattern Restrictive pattern 
FVC normal or slightly decreased FVC decreased 
FEV 1 decreased FEVl decreased 
FEV l/FVC decreased FEVl/FVC normal or slightly increased 
Determining the disease pattern is more relevant to clinical diagnosis and treatment than to 
workplace spirometry screening, where early identification of a ventilatory defect is the primary 
ojective. 
Once a ventilatory defect is identified, its severity is determined using the percentage of FEVl loss 
(for obstructive deficits) or the percentage of FVC loss (for restrictive deficits) [ATS 19911. 
Medical followup to determine the nature of any loss in FEV1 or FVC may include further testing 
such as TLC, airways resistance, and diffusing capacity. 
Similarly, FEV1/FVC should not be used to determine the severity of the deficit because both FEVl 
and FVC may be decreased-either as a result of a restrictive or a mixed ventilatory defect. Such 
a pattern of parallel reduction in FVC and FEVl has been reported among U.S. and U.K. coal 
miners [Attfield and Hodous 1992; Soutar and Hurley 19861 (see section 4.2.2 for discussion of 
epidemiological studies of lung function and respiratory symptoms in coal miners). 
The LLN for a spirometric test may be defined as the 5th percentile of the reference population 
[ATS 19911 (see section 6.5.4 for further discussion). Patterns of restrictive and obstructive 
ventilatory defects observed with other lung function tests are listed in Table 6- 1. Figure 6-1 
illustrates determination of FEVl and FVC on a spirogram. 
6.5.2 Quality Control and Instrumentation 
Criteria for improving the accuracy and reproducibility of spirometry test results include the 
following [ATS 199 11: 
Adherence to ATS guidelines for equipment performance and calibration [ATS 1987a, 
19791 
Maintenance of spirometer temperature between 17" and 40°C to reduce temperature-re- 
lated errors 
Validation of computer calculations following any changes in hardware or software 
Quality assurance reviews by each laboratory to maintain the precision and accuracy of 
spirometry measurements, and 
Provision of high-quality of training for technicians (technicians should complete a NIOSH- 
approved course on spirometry, and laboratories should receive NIOSH certification) 
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Figure 6-1. FVC and FEVi on a normal volume-time curve. 
Two basic types of spirometers are available for determining FEV1, FVC, or FEVl/FVC: the flow 
spirometer and the volume spirometer [Hankinson 19931. The flow spirometer measures the rate 
at which air is exhaled, and it must integrate flow to determine volume. The volume spirometer 
collects exhaled air and directly measures volume. A significant advantage of the volume spirometer 
is its simplicity and direct measurement of volume; a significant disadvantage is that a small 
error in estimating zero flow can affect the resulting volume, particularly for measurements of 
FVC [Hankinson 19931. Further information about quality control, instrumentation, and inter- 
pretation of spirometry tests is provided in the ATS reports mentioned above [ATS 1991, 1987a, 
19791, in other publications [Hankinson 1993; McKay and Lockey 1992; Harber and Lockey 19921, 
and in Appendix G of this document. Hankinson et al. [I9941 describe a method that uses 
ceramic flow sensors to estimate body temperature and pressure-saturated (BTPS) correction 
factors for spirometers. 
6.5.3 ATS Acceptability and Reproducibility Criteria for Spirometry Tests 
The ATS criteria for acceptability of a spirometry curve is based on the technician's observation 
that the individual performed the test with a smooth, continuous exhalation, apparent maximal 
effort, and a satisfactory start-and without coughing, glottis closure, early termination, a leak, or 
an obstructed mouthpiece [ATS 1987al. A minimum of three acceptable maneuvers are required 
according to ATS guidelines [ATS 1987al. The spirometry testing administered as part of the 
National Study of Coal Workers' Pneumoconiosis includes five maneuvers, and the maximum 
FEVl and FVC values are used for epidemiological analysis [Attfield and Hodous 19921. 
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The ATS acceptability and reproducibility criteria are intended to be spirometry testing goals-not 
criteria for determining the inclusion or exclusion of subjects in an epidemiological study. As 
shown in two separate studies [Kellie et al. 1987; Eisen et al. 1984, 19831, the ATS reproducibility 
criteria to determine which subjects should be included in an epidemiological analysis resulted in 
biased estimates of FEV1. Eisen [I9871 reported that individuals with persistent test failure had 
twice the annual average rate of FEVl decline than those without persistent test failure. Kellie et 
al. [I9871 found that coal miners who failed the reproducibility criteria had a lower mean FEVl 
and significantly more respiratory symptoms (i.e., cough, phlegm, wheeze, and dyspnea) than 
miners with reproducible tests. 
Height has also been shown to affect a person's ability to meet ATS reproducibility criteria (i.e., 
shorter persons have more difficulty than taller subjects in satisfying ATS reproducibility criteria) 
[Hankinson and Bang 19911. The largest FVC and FEVl should be reported regardless of the 
spirometry curve(s) on which they occur [Hankinson 1986; ATS 1987al. Miller and Scacci [I9811 
have suggested criteria that can be used to determine whether an individual has used full effort. 
NIOSH recommends that the ATS acceptability and reproducibility guidelines be used to describe 
spirometry test results but not to dismiss a finding of abnormality. 
6.5.4 Cross-Sectional Spirometry Testing 
For spirometry used to assess a person's lung function at one point in time, his or her values for 
FEV1, FVC, and FEV1/FVC are compared with normal reference values for persons of similar 
gender, age, height, and race. This approach (referred to as cross-sectional spirometry testing) is 
used to determine whether spirometry test values are within normal limits. 
The percentile of the lung function distribution chosen to define the LLN depends on the desired 
levels of sensitivity and specificity. The 5th percentile has been recommended for use as the LLN 
in clinical evaluation and diagnosis [ATS 199 I].$ Thus, spirometry values below the 5th percentile 
are below the expected normal range. Although the use of the 5th percentile as the LLN provides 
a high degree of specificity (i.e., few false positives), it is implicitly insensitive to detecting early 
abnormalities, particularly in a healthy population. Greater sensitivity for screening purposes may 
result from using a higher percentile (e.g., the 10th) as the cutoff point for recommending further 
medical evaluation or testing [WHO 1995].** 
NIOSH recommends that the 5th percentile be used to define the LLN for the recommended 
spirometry tests in the medical screening and surveillance program for coal miners (Appendix E). 
Miners with a confirmed finding of FEV1, FVC, or FEV1/FVC below the LLN are eligible to 
participate in medical intervention programs (see Section 6.4.4). 
NIOSH also recommends that the 10th percentile be used as the cutoff point for recommending 
further evaluation. Thus, miners with lung function at or below the 10th percentile of the 
distribution should be advised to seek further clinical evaluation from a qualified health care provider. 
%'he 5th percentile is equivalent to the "normal 95th percentile" used by Knudson et al. [1983]. 
** 
WHO [I9951 uses the terminology from Knudson et al. [I9831 (i.e., 90th percentile). 
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If a miner has respiratory symptoms that suggest an abnormality (whether or not his or her lung 
function values are below the LLN), he or she may submit medical records and request a review 
for eligibility to participate in the medical intervention programs. 
Spirometry test results that are less than 80% of the predicted values are often used to identify 
abnormal results, but this criterion has no statistical basis [ATS 19911 and is not recommended. 
If the data used for deriving the prediction equation are distributed normally (i.e., Gausian 
distribution) with variability reasonably constant over the age range of interest, then the LLN may 
be calculated as a defined percentile point of that distribution using the estimated standard error. 
However, this approach is not recommended because assumptions of normality and homogeneity 
of variance are rarely met in actual spirometric surveys of adults [Knudson et al. 19831. Instead, 
Knudson et al. [I9831 advise determining the LLN as a defined lower percentile point of the actual 
distribution of data. 
The Knudson et al. El9831 equations are recommended as the basis for the normal reference values 
for spirometry tests (i.e., the LLN for FEV1, FVC, and FEVlIFVC) of U.S. coal miners for the 
following reasons: 
The analyses described by Knudson et al. 119831 meet the methodological, epidemiological, 
and statistical criteria recommended by the ATS [I99 11 for the selection of reference values. 
The estimate of the age-related decline in FEVl found by Knudson et al. 119831 is very 
similar to that reported by Attfield and Hodous [I9921 for nonsmoking coal miners. 
The Knudson et al. [I9831 data are based on cross-sectional studies of lifetime nonsmokers; 
thus, the spirometry test results will be applicable to the respiratory health surveillance of 
miners as a group and to the medical evaluation of individual miners for diagnosis and other 
clinical purposes. 
As additional data become available, NIOSH may update these recommendations for reference 
values in spirometry testing. In particular, future studies may provide reference values for several 
ethnic groups that are not currently available in the literature. 
6.5.5 Longitudinal Spirometry Testing 
Longitudinal spirometry used in medical screening allows comparisons of a worker's preplacement 
lung function values with those determined in later spirometric examinations. Such periodic 
spirometry testing may be useful for early identification of a worker with excessive loss of lung 
function (i.e., before the loss is apparent from cross-sectional testing) [Hankinson and Wagner 
19931. This identification is possible because workers as a group are often healthier than the 
general population and have above-average lung function [Becklake and White 19931. Thus, 
comparing a worker's lung function values with general population reference values may not detect 
an actual loss in that worker's lung function [Hankinson and Wagner 19931. About half of a worker 
population may benefit from longitudinal (in addition to cross-sectional) evaluation of spirometry 
[Hankinson and Wagner 19931. 
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Hankinson and Wagner [I9931 recommend establishing a baseline FEVl value for each worker 
from several initial spirometric examinations. They then recommend calculating the longitudinal 
LLN by taking 85 percent of this baseline value minus the expected decline over a period of time 
(based on the individual's age). 
6.5.6 Additional Medical Tests of Lung Function 
Additional lung function tests may be required for further evaluation of miners with abnormal 
spirometric examinations or with respiratory symptoms. Such tests may be too complicated or 
expensive to administer during routine screening, or they may have large variability within a 
normal population [Miller and Scacci 198 1; Hankinson 1986; WHO 19951. 
Recommended methods are available for measuring the diffusing capacity of the lung for carbon 
monoxide (DLCO) [Ferris 19781 and for calculating predicted values [Crapo and Morris 19811. 
Changes in the membrane-diffusing capacity or in the capillary volume that are caused by structural 
lung damage can influence the diffusing capacity of the lung willer and Scacci 19811. The 
single-breath method of measuring DLCO is the most widely used and best standardized method 
of measuring diffusing capacity [Gold and Boushey 1988; Hankinson 19861. Because DLCO can 
be abnormal in numerous respiratory disorders, the test lacks specificity for work-related respira- 
tory diseases. Also, cigarette smoking has been associated with reduced DLCO (because of 
elevated carboxyhemoglobin) and should be considered in the diagnosis [Hankinson 19861. 
Measuring the DLCO is indicated when other tests such as spirometry do not show sufficient lung 
impairment to explain a patient's respiratory symptoms [Hankinson 1986; Miller and Scacci 198 11. 
6.6 OTHER ISSUES PERTAINING TO RECOMMENDATIONS FOR MEDICAL 
SCREENING AND SURVEILLANCE 
6.6.1 Evaluating the Work-Relatedness of COPD Among Coal Miners 
The evidence implicating exposure to coal mine dust as a cause of COPD in coal miners has been 
reviewed in Chapter 4 and is used in Chapter 7 as part of the basis for the NIOSH REL for respirable 
coal mine dust. Becklake [I9851 concluded that the causal link between occupational exposure 
and chronic airflow limitation among coal miners has been demonstrated "beyond reasonable 
doubt." Becklake's conclusion refers to the epidemiological evidence from studies of exposures 
and responses in groups of miners. In these studies [Attfield and Hodous 1992; Seixas et al. 1993, 
1992; Marine et al. 1988; Soutar et al. 1988; Soutar and Hurley 1986; Rogan et al. 19731, the 
variability among individuals' lung function responses to similar exposures implies that a certain 
proportion of miners will respond either more or less severely than the average. Among miners 
who respond more severely than the average, some may have clinically significant reductions in 
lung function, as shown by Marine et al. [1988]. Soutar and Hurley [I9861 found that studies 
limited to working miners may underestimate the clinical importance of dust-associated reductions 
in lung function. Hurley and Soutar [I9861 identified a subgroup of coal miners (including those 
who had left the industry voluntarily before normal retirement age) for whom the average effect 
of dust exposure on reduction in FEVl was more than twice that reported by Marine et al. [1988]. 
The findings of these epidemiological studies indicate that exposure to coal mine dust may lead 
to clinically significant COPD. But as Becklake [I9851 notes, it is unlikely that medical evidence 
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could provide scientific proof of the work-relatedness of a particular case of COPD, even though 
"a reasonable statement of probability" may often be obtained. Kusnetz and Hutchinson [I9791 
identified the various elements that need to be considered when physicians attempt to make such 
an individual assessment of probability: 
Verification of convincing epidemiological evidence that occupational exposure may cause 
COPD 
Clinical evidence that the disease exists in the individual concerned 
Evidence that there has been an exposure of sufficient degree or duration to result in disease 
An assessment of other relevant factors such as nonoccupational exposures that might cause 
COPD or other special circumstances. 
The spirometric examinations and questionnaires on respiratory symptoms and work history 
(which are included in the recommended medical screening and surveillance program for coal 
miners) will provide important information for effective workplace surveillance, medical diagno- 
ses, and individual advice to miners. 
6.6.2 Medical Intervention Strategies 
The risk of developing PMF increases with increasing initial category of simple CWP [Attfield 
and Seixas 1995; Attfield and Morring 1992b; Hurley and Maclaren 1987; Hurley et al. 1987; 
McLintock et al. 1971; Cochrane 19621. Furthermore, the risk of progression to a higher category 
of simple CWP increases with increasing intensity of exposure (mean dust concentration) 
[Jacobsen et al. 1970, 19711 and increasing cumulative exposure (i.e., intensity x duration) 
[Jacobsen 1973, 19791. Thus, the risk of PMF increases systematically both with initial category 
of simple CWP and with the amount of progression (over 5-year periods) from each initial category 
(including categories 010, 011, and 110) [McLintock et al. 19711. The amount of time spent in a 
disease category of simple CWP may also influence the risk of progression to a higher category 
[Morfeld et al. 19921. 
The weight of evidence from these studies suggests that a reduction in worker exposures to respirable 
coal mine dust will decrease the risk of simple CWP progression and thus the risk of PMF. However, 
other factors may influence the effectiveness of dust reduction in decreasing the risk of disease 
progression. Cumulative exposure and residence time of dust in the lungs may be important factors 
in the development of PMF [Maclaren et al. 1989; Hurley et al. 19871. Maclaren and Soutar [I9851 
found that 32% of the miners who developed PMF after they left mining had no evidence of CWP 
(i.e., category 0) when they terminated their employment in mining. The effectiveness of dust 
reduction may also depend on the magnitude of that reduction. Hurley and Maclaren [I9871 
estimated that just 1 in 10,000 cases of PMF would be prevented if all miners who had developed 
simple CWP category 110 or greater at a mean concentration of 2.0 mg/m3 of respirable coal mine 
dust were then allowed to work at a mean concentration of 1.0 mg/m3. However, the same report 
also shows that reducing average dust concentrations from 2 to 1 mg/m3 over a 40-year working 
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lifetime would more than halve the risk of PMF-from between 7 and 18 cases per 1,000, to between 
3 and 7 cases per 1,000, depending on coal rank [Hurley and Maclaren 19871. 
The effectiveness of reducing exposures to respirable coal mine dust has not been adequately 
studied with regard to reversing or reducing lung function deficits. However, some evidence shows 
that reduction or cessation of smoking can at least partially reverse the functional abnormalities 
associated with smoking [McCarthy et al. 19761 and the structural changes in the peripheral airways 
of asymptomatic young smokers [Ingram and O'Cain 19711. These studies of smoking suggest 
that reducing or ceasing exposures to other contaminants associated with airways obstruction and 
loss of lung function (e.g., respirable coal mine dust and respirable crystalline silica) may also 
effectively reverse or further reduce adverse effects. NIOSH therefore recommends, as a prudent 
public health measure, that miners be permitted to work in a low-dust environment if they have 
evidence of COPD caused or exacerbated by exposure to coal mine dust. 
Further research is needed to evaluate the effectiveness of medical interventions such as reducing 
or ceasing exposures to respirable coal mine dust or respirable crystalline silica. Any analysis of 
the effectiveness of the transfer program would need to consider possible bias from the low rate 
of participation: only 23% of eligible coal miners (2,119 of 9,138 miners) elected to participate 
Wagner and Spieler 19901. Goldenhar and Schulte [I9941 have described additional methodological 
issues in intervention research. 
A related research need is to evaluate the availability of mine areas where exposures to respirable 
coal mine dust and respirable crystalline silica are as far below the respective RELs as feasible. 
The tables in Appendix B show that mean concentrations for most occupations have been below 
the PEL of 1 mg/m3 for miners transferred under 30 CFR 90. However, the mean concentrations 
for some occupations (e.g., roof bolter and continuous miner helper) exceed the PEL of 1 mg/m3, 
and a substantial percentage of samples show measured concentrations greater than 1 mg/m3. 
Limited data from sampling required for miners transferred under 30 CFR 90 also show that 
concentrations of respirable crystalline silica exceeded the NIOSH REL and the MSHA PEL for 
some occupations. NIOSH advocates primary prevention (through reducing exposures) rather than 
secondary intervention as the most effective means of eliminating occupational diseases. 
